Impact of tissue heterogeneity corrections in stereotactic body radiation therapy treatment plans for lung cancer

Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans

BACKGROUND The aim of this study is to evaluate the radiobiological impact of Acuros XB (AXB) vs. Anisotropic Analytic Algorithm (AAA) dose calculation algorithms in combined dose-volume and biological optimized IMRT plans of SBRT treatments for non-small-cell lung cancer (NSCLC) patients. METHODS Twenty eight patients with NSCLC previously treated SBRT were re-planned using Varian Eclipse (V...

Stereotactic body radiation therapy (SBRT) for lung cancer

Stereotactic body radiation therapy (SBRT) has evolved over the past 15 years and revolutionized the management of early stage non-small cell lung cancer (NSCLC). Compared to conventional radiation therapy, SBRT offers superior outcomes, lower costs and greater patient convenience.1 SBRT likewise offers local control and cancer outcomes approaching surgical resection2-8 with lower risk of treat...

Stereotactic body radiation therapy for inoperable early stage lung cancer.

CONTEXT Patients with early stage but medically inoperable lung cancer have a poor rate of primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) with current management. OBJECTIVE To evaluate the toxicity and efficacy of stereotactic body radiation therapy in a high-risk population of patients with early stage but medically inoperable lung cancer. DESIGN, S...

Stereotactic Body Therapy Radiation for the Treatment of Early Stage Non Small Cell Lung Cancer AUTHOR:

Stereotactic Body Radiation Therapy for the Treatment of Early Stage Non Small Cell Lung Cancer

The California Technology Assessment Forum was requested to review the scientific evidence for the use of Stereotactic Body Radiation Therapy (SBRT) for the treatment of early stage non small cell lung cancer (NSCLC) in medically inoperable patients. Given that the major treatment goal for non small cell lung cancer is to obtain local control, is SBRT a viable therapeutic option for patients wh...